Robertson Stephens Wealth Management LLC Purchases 8,891 Shares of iShares Biotechnology ETF $IBB

Robertson Stephens Wealth Management LLC lifted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 363.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,334 shares of the financial services provider’s stock after purchasing an additional 8,891 shares during the period. Robertson Stephens Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $1,913,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the company. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the second quarter worth about $25,000. Ashton Thomas Securities LLC bought a new stake in iShares Biotechnology ETF in the third quarter worth about $36,000. Parkside Financial Bank & Trust raised its position in iShares Biotechnology ETF by 48.6% in the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after acquiring an additional 87 shares during the period. Close Asset Management Ltd raised its position in iShares Biotechnology ETF by 25.5% in the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after acquiring an additional 70 shares during the period. Finally, Founders Financial Alliance LLC raised its position in iShares Biotechnology ETF by 605.7% in the third quarter. Founders Financial Alliance LLC now owns 374 shares of the financial services provider’s stock worth $54,000 after acquiring an additional 321 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.8%

Shares of IBB stock opened at $167.27 on Friday. iShares Biotechnology ETF has a 52 week low of $116.25 and a 52 week high of $179.64. The firm’s 50-day simple moving average is $169.84 and its two-hundred day simple moving average is $168.53.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were given a $0.1218 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 annualized dividend and a yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.